Diabetic kidney disease: from face to prevention, diagnosis and early intervention.
PDF (Español (España))
HTML (Español (España))

How to Cite

1.
Rico Fontalvo JE. Diabetic kidney disease: from face to prevention, diagnosis and early intervention. Rev. Colomb. Nefrol. [Internet]. 2020 Aug. 6 [cited 2022 Aug. 13];7(2). Available from: https://revistanefrologia.org/index.php/rcn/article/view/506
https://doi.org/10.22265/acnef.7.2.506
PDF (Español (España))
HTML (Español (España))

References

International Diabetes Federation (IDF). IDF Diabetes Atlas 2019. 9th ed. Belgium: IDF; 2019.

Lopera-Vargas JM, Rico-Fontalvo JE, Melgarejo E, Castillo-Barrios GA, Ramírez-Rincón A, Gómez AM, et al. Efectos de terapias farmacológicas para el control glucémico en pacientes con diabetes mellitus tipo 2 en los desenlaces vasculares. Rev Colomb. Nefrol. 2020,7(1):44-59. https://doi.org/10.22265/acnef.7.1.372.

Rico-Fontalvo JE. Nefropatía diabética. En: Restrepo CA, Buitrago CA, Torres J, Serna J, editores. Nefrología Básica 2. 2da ed. Bogotá D.C.: Asociación Colombiana de nefrología;2012.

Li J, Albajrami O, Zhuo M, Hawley C-E, Paik JM. Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2020. ttps://doi.org/10.2215/CJN.02690320.

Lin YC, Chang YH, Yang SY, Wu KD, Chu TS. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117(8):662-75. https://doi.org/10.1016/j.jfma.2018.02.007.

American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S66-S76. https://doi.org/10.2337/dc20-S006.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Revista Colombiana de Nefrología

Dimensions


PlumX


Downloads

Download data is not yet available.